| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
regulator of G protein signaling 17 | 0.716 | 0.346 | 0.27 |
|
phenotype | 0.100 | None | 1.000 | 5 | 5 | 2015 | 2019 | ||||||||
|
long intergenic non-protein coding RNA 907 | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 5 | 3 | 2015 | 2019 | |||||||||
|
glutamate ionotropic receptor delta type subunit 1 | 0.743 | 0.385 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 5 | 4 | 2015 | 2019 | ||||||||
|
PDZ domain containing ring finger 4 | 0.805 | 0.269 | 9.1E-07 |
|
phenotype | 0.100 | None | 1.000 | 5 | 4 | 2015 | 2019 | ||||||||
|
potassium two pore domain channel subfamily K member 3 | 0.584 | 0.654 | 0.90 |
|
phenotype | 0.100 | None | 1.000 | 5 | 3 | 2015 | 2019 | ||||||||
|
kinesin light chain 1 | 0.695 | 0.385 | 0.37 |
|
phenotype | 0.100 | None | 1.000 | 5 | 1 | 2015 | 2019 | ||||||||
|
SH3 domain binding kinase 1 | 0.805 | 0.231 | 0.37 |
|
phenotype | 0.100 | None | 1.000 | 5 | 1 | 2015 | 2018 | ||||||||
|
zinc finger homeobox 3 | 0.621 | 0.654 | 0.45 |
|
phenotype | 0.100 | None | 1.000 | 5 | 6 | 2016 | 2019 | ||||||||
|
hydroxysteroid 17-beta dehydrogenase 12 | 0.722 | 0.308 | 4.0E-04 |
|
phenotype | 0.100 | None | 1.000 | 5 | 6 | 2015 | 2018 | ||||||||
|
phosphodiesterase 1C | 0.700 | 0.423 | 5.4E-09 |
|
phenotype | 0.100 | None | 1.000 | 5 | 5 | 2015 | 2019 | ||||||||
|
glutaminyl-peptide cyclotransferase like | 0.805 | 0.346 | 1.6E-08 |
|
phenotype | 0.100 | None | 1.000 | 5 | 1 | 2010 | 2018 | ||||||||
|
UHRF1 binding protein 1 | 0.769 | 0.269 | 4.5E-13 |
|
phenotype | 0.100 | None | 1.000 | 5 | 5 | 2012 | 2018 | ||||||||
|
fidgetin, microtubule severing factor | 1.000 | 0.038 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 5 | 3 | 2015 | 2019 | ||||||||
|
RAB27B, member RAS oncogene family | 0.608 | 0.692 | 3.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 5 | 4 | 2016 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.100 | None | 1.000 | 5 | 1 | 2016 | 2019 | ||||||||
|
F-box and leucine rich repeat protein 17 | 0.931 | 0.077 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 5 | 5 | 2015 | 2019 | ||||||||
|
solute carrier family 22 member 3 | 0.531 | 0.846 | 7.8E-10 |
|
phenotype | 0.100 | None | 1.000 | 5 | 3 | 2015 | 2019 | ||||||||
|
gametogenetin binding protein 2 | 0.700 | 0.423 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 5 | 3 | 2015 | 2019 | ||||||||
|
G protein-coupled receptor 61 | 1.000 | 0.077 | 0.78 |
|
phenotype | 0.100 | None | 1.000 | 5 | 2 | 2015 | 2019 | ||||||||
|
cholecystokinin | 0.453 | 0.846 | 3.3E-05 |
|
phenotype | 0.100 | None | 1.000 | 5 | 5 | 2012 | 2019 | ||||||||
|
scavenger receptor class B member 2 | 0.606 | 0.615 | 8.9E-05 |
|
phenotype | 0.100 | None | 1.000 | 5 | 2 | 2015 | 2019 | ||||||||
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.579 | 0.654 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 5 | 4 | 2015 | 2019 | ||||||||
|
BORCS7-ASMT readthrough (NMD candidate) | 0.805 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 4 | 3 | 2017 | 2019 | |||||||||
|
SWI/SNF complex antagonist associated with prostate cancer 1 | 0.751 | 0.192 |
|
phenotype | 0.100 | None | 1.000 | 4 | 3 | 2015 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1440 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 4 | 4 | 2017 | 2019 |